Regencell Bioscience Holdings Limited (RGC) Company Information

Complete company information for RGC including business overview, key executives, headquarters location, corporate structure, and company details. Learn about RGCleadership team and business operations.

Company Profile

Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Website: https://www.regencellbioscience.com

Headquarters: Chinachem Leighton Plaza, Causeway Bay, , Hong Kong

Phone: 852 2155 0823

Full Time Employees: 10

Key Executives:

Founder, Chairman & CEO: Mr. Yat-Gai Au

Financial Controller, CFO & Principal Financial Officer: Ms. Michelle Chan

COO, Chief Strategy Officer & Director: Mr. Wai Hong ChungTotal Pay: $245,642

Senior Vice President of Project Management: Ms. Antonia Assang

Chief Business Officer: Mr. Yat-Pui Au

Additional Information:

Market Cap: $10.16B

Enterprise Value: $10.38B

Shares Outstanding: 494.49M

Float Shares: 18.43M

Last Fiscal Year End: 6/30/2025

Next Fiscal Year End: 6/30/2026

Most Recent Quarter: 6/30/2025

Last Stock Split: 6/16/2025(38:1)